Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PD184352 | 0.1 | uM | 1 | HGF | 0 | |||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | HGF | 0 | |||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | HGF | 0 | |||||
N2586 | Tofacitinib | 0.3 | uM | 1 | HGF | 0 | |||||
N2586 | IKK16 | 2.0 | uM | 1 | HGF | 0 | |||||
N2586 | 1 | HGF | 0 | ||||||||
RA2159 | Visfatin | 1 | ng/mL | 1 | HGF | 53.0 | 57 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 56.0 | 87 | |
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 38.0 | 74 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 43.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 41.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 39.0 | 48 | |
N2586 | Visfatin | 1 | ng/mL | 1 | HGF | 50.5 | 50 | ||||
N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 49.0 | 48 | |
N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 49.0 | 52 | |
N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 49.5 | 48 | |
N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 54.0 | 46 | |
N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | HGF | 49.0 | 29 | |
0 | HGF | 17.0 | 59 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 1 | HGF | 50.5 | 62 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | HGF | 62.5 | 52 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | HGF | 51.0 | 56 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | HGF | 58.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | HGF | 52.0 | 64 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | HGF | 39.5 | 86 |